Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

There are several reports regarding the role of therapeutic diets for patients with non-alcoholic fatty liver disease (NAFLD). Therefore, the aim of this study was to determine the effects of a low-calorie, low-carbohydrate soy-containing diet on lipid profiles, liver enzymes, and coagulating factor...

Full description

Saved in:
Bibliographic Details
Published inNutrition (Burbank, Los Angeles County, Calif.) Vol. 30; no. 7-8; pp. 814 - 821
Main Authors Kani, Ali Hashemi, Alavian, Seyed Moayed, Esmaillzadeh, Ahmad, Adibi, Peyman, Azadbakht, Leila
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2014
Elsevier
Elsevier Limited
Subjects
Soy
Soy
Online AccessGet full text
ISSN0899-9007
1873-1244
1873-1244
DOI10.1016/j.nut.2013.11.008

Cover

More Information
Summary:There are several reports regarding the role of therapeutic diets for patients with non-alcoholic fatty liver disease (NAFLD). Therefore, the aim of this study was to determine the effects of a low-calorie, low-carbohydrate soy-containing diet on lipid profiles, liver enzymes, and coagulating factors in patients with NAFLD. This was a randomized parallel clinical trial involving 45 patients with NAFLD. The participants consumed three kinds of diets for 8 wk. Patients were randomly assigned to consume a low-calorie diet; a low-calorie, low-carbohydrate diet; or a low-calorie, low-carbohydrate soy-containing diet. Measurements were done according to the standard method. Changes in weight were not significantly different in the three groups. The low-calorie, low-carbohydrate soy-containing diet could reduce alanine aminotransferase (–15.2 ± 12.1 versus –6.8 ± 4.6 in the low-calorie, low-carbohydrate diet, and –6.4 ± 4.4 IU/L in the low-calorie diet; P = 0.02) and serum fibrinogen levels (–49.1 ± 60.1 versus –12.9 ± 8.1 and –17.4 ± 8.4 g/L, respectively; P = 0.01). Reductions in aspartate aminotransferase were significantly higher in the low-calorie, low-carbohydrate soy-containing group. Changes in lipid profiles did not differ significantly between the groups. The soy-containing diet did reduce malondialdehyde more than the other diets (P = 0.01). A low-calorie, low-carbohydrate soy-containing diet could have beneficial effects on liver enzymes, malondialdehyde, and serum fibrinogen levels in patients with NAFLD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0899-9007
1873-1244
1873-1244
DOI:10.1016/j.nut.2013.11.008